FDA Person
FDAMayar M. Mussa
View detailed information about Mayar M. Mussa, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 48 inspections of 44 companies, 2023–2026.
Inspections (48)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 28, 2026 | Bristol Myers Squibb | Not classified | #1339354 | |
| September 16, 2026 | Samsung Bioepis US Inc. | Not classified | #1337000 | |
| August 27, 2026 | ANI Pharmaceuticals, Inc | Not classified | Postmarket Surv. and Epidemiology | #1288062 |
| August 14, 2026 | Merck & Co. Inc | Not classified | #1329118 | |
| July 31, 2026 | Eugia US LLC | Not classified | Postmarket Surv. and Epidemiology | #1286306 |
| July 15, 2026 | Bayer Healthcare Pharmaceuticals Inc. | Not classified | #1320574 | |
| June 25, 2026 | TAIHO Oncology, Inc | Not classified | #1325830 | |
| May 22, 2026 | Keun-Wook Lee, M.D., Ph.D. | Not classified | Bioresearch Monitoring | #1320378 |
| May 15, 2026 | Sae-Won Han, M.D., Ph.D. | Not classified | #1320880 | |
| April 24, 2026 | Avotres Inc. | Not classified | Human Cellular, Tissue, and Gene Therapies | #1313782 |
| March 27, 2026 | Omnivium Pharmaceuticals LLC | Not classified | #1310504 | |
| March 13, 2026 | Merck & Co. Inc | Not classified | #1305632 | |
| February 27, 2026 | SOMERSET THERAPEUTICS LLC | Not classified | #1305652 | |
| February 12, 2026 | Waylis Therapeutics | Not classified | Postmarketing Surveillance and Epidemiology: Human Drugs | #1303428 |
| January 15, 2026 | Kessler Foundation IRB | Not classified | #1299430 | |
| December 18, 2025 | Merck & Co. Inc | Not classified | #1283890 | |
| November 24, 2025 | Hackensack Meridian Health IRB | Not classified | #1293604 | |
| November 6, 2025 | ITM USA, Inc. | Not classified | #1291928 | |
| October 9, 2025 | Haisco-USA Pharmaceuticals, Inc. | VAI | Bioresearch Monitoring: Human Drugs | #1286348 |
| September 11, 2025 | Frank Lee, M.D. | Not classified | #1282994 |
Documents (17)
- 483 · Haisco-USA Pharmaceuticals, Inc. · October 9, 2025
- 483 · Novo Nordisk Inc. · February 7, 2025
- 483 · Kessler Foundation IRB · January 15, 2026
- 483 · Haisco-USA Pharmaceuticals, Inc. · October 9, 2025
- 483 · Martin E. Gutierrez · November 20, 2024
- 483 · Acrotech Biopharma Inc. · November 18, 2024
- 483 · Daiichi Sankyo, Inc. · August 1, 2025
- 483 · Wockhardt USA LLC · June 6, 2024
- 483 · Teva Pharmaceuticals USA, Inc · September 29, 2023
- 483 · Deborah A. Goss, M.D. · March 17, 2025
- 483 · Vinay Sikand, M.D. · September 14, 2023
- 483 · Quagen Pharmaceuticals LLC · November 8, 2023
- 483 · Novartis Pharmaceuticals Corporation · August 21, 2023
- 483 · Waylis Therapeutics · February 12, 2026
- 483 · Unknown Company · February 12, 2026
- 483 · Avotres Inc. · April 24, 2026
- 483 · Keun-Wook Lee, M.D., Ph.D. · May 22, 2026
Person Information
Name
Mayar M. Mussa
Role
INVESTIGATOR
ID: 4f39b1c8-93a6-4bc9-a800-5f802db48be6
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.